West Pharmaceutical Services SEC filings, summarized
We read every West Pharmaceutical Services 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track WST in your inbox
Add West Pharmaceutical Services to your watchlist — free, every morning.
Recent filings
West Pharmaceutical raises 2026 guidance after strong second-quarter results
West Pharmaceutical reported second-quarter 2026 net sales of $872.3 million, up 13.8% year over year, while adjusted diluted EPS rose 28.8% to $2.37;…
West Pharmaceutical raises 2026 sales and adjusted EPS guidance after strong Q2
West Pharmaceutical reported second-quarter 2026 sales of $872.3 million, up 13.8% year over year, and adjusted diluted EPS of $2.37, up 28.8%, with organic…
West Pharmaceutical ($WST) filed Form 8‑K (Item 9.01) to furnish a press release dated Mar 9, 2026…
West Pharmaceutical ($WST) filed Form 8‑K (Item 9.01) to furnish a press release dated Mar 9, 2026 (Exhibit 99.1). No financial statements included; cover…
West Pharmaceutical says Mr.
West Pharmaceutical says Mr. Green intends to retire from the Company and the Board; press release furnished as Exhibit 99.1. Filing dated 2026-03-09. $WST…
West Pharmaceutical Services ($WST) CEO/President/Chair Eric M.
West Pharmaceutical Services ($WST) CEO/President/Chair Eric M. Green informed the Board on Mar 6, 2026 of his intent to retire once a successor is hired.…
West Pharmaceutical Services files Form 8‑K (Feb 12, 2026) adding a Press Release (Ex.99.1) and Investor…
West Pharmaceutical Services files Form 8‑K (Feb 12, 2026) adding a Press Release (Ex.99.1) and Investor Presentation (Ex.99.2). 📄 $WST #8K #Pharma Item…
WEST Pharmaceutical ($WST) filed a Regulation FD disclosure (Item 7.01) on 2026-02-12, incorporating Item…
WEST Pharmaceutical ($WST) filed a Regulation FD disclosure (Item 7.01) on 2026-02-12, incorporating Item 2.02 (Results of Operations & Financial…
West Pharmaceutical ($WST) filed an 8‑K (Item 2.02) on Feb 12, 2026 announcing Q4 & full‑year 2025…
West Pharmaceutical ($WST) filed an 8‑K (Item 2.02) on Feb 12, 2026 announcing Q4 & full‑year 2025 results; press release attached as Exhibit 99.1.…